Literature DB >> 12115998

Sero-epidemiological patterns of Epstein-Barr and herpes simplex (HSV-1 and HSV-2) viruses in England and Wales.

Marianne C Morris1, W John Edmunds, Louise M Hesketh, Andrew J Vyse, Elizabeth Miller, Peter Morgan-Capner, David W G Brown.   

Abstract

The aim was to carry out a population-based sero-prevalence survey of Epstein-Barr virus (EBV) across a wide age range in England and Wales and to identify any associations between EBV and herpes simplex virus types one and two (HSV-1 and 2). Sera from an age-stratified sample of 2,893 individuals, submitted for diagnostic purposes to 15 public health laboratories in England and Wales in 1994, were tested for immunoglobulin G (IgG) antibody to EBV. The samples had been tested previously for IgG antibody to HSV-1 and HSV-2. The serological profile of EBV was consistent with an endemic infection with peaks in transmission in those less than 5 years old and in young adults. An age adjusted analysis found a significant association between EBV and HSV-1 seropositivity that is most likely explained by similarities in their mode of transmission. The very low seroprevalence of HSV-2 in this sample complicated the comparisons of EBV and HSV-1 with HSV-2. Any associations were most likely explained by chance. Given the association between EBV and HSV-1, it is likely that recently documented epidemiological changes in HSV-1 also apply to EBV. Continuing surveillance of these herpes viruses is necessary as the predicted changes could have a significant public health impact, especially in the young adult population. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12115998     DOI: 10.1002/jmv.10132

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  16 in total

1.  Seroprevalence of antibodies against serogroup C meningococci in England in the postvaccination era.

Authors:  Caroline L Trotter; Ray Borrow; Jamie Findlow; Ann Holland; Sarah Frankland; Nick J Andrews; Elizabeth Miller
Journal:  Clin Vaccine Immunol       Date:  2008-09-30

2.  Mannose-binding lectin genotypes and susceptibility to epstein-barr virus infection in infancy.

Authors:  Jeppe T Friborg; Ruth F Jarrett; Anders Koch; Peter Garred; June M L Freeland; Andreas Andersen; Mads Melbye
Journal:  Clin Vaccine Immunol       Date:  2010-07-07

3.  The Potential for EBV Vaccines to Prevent Multiple Sclerosis.

Authors:  Peter A Maple; Alberto Ascherio; Jeffrey I Cohen; Gary Cutter; Gavin Giovannoni; Claire Shannon-Lowe; Radu Tanasescu; Bruno Gran
Journal:  Front Neurol       Date:  2022-06-24       Impact factor: 4.086

4.  Relative seroprevalence of human herpes viruses in patients with chronic lymphocytic leukaemia.

Authors:  C Steininger; L Z Rassenti; K Vanura; K Eigenberger; U Jäger; T J Kipps; C Mannhalter; S Stilgenbauer; T Popow-Kraupp
Journal:  Eur J Clin Invest       Date:  2009-06       Impact factor: 4.686

5.  The correlation between EBV viral load in the palatine tonsils of patients with recurrent tonsillitis and concurrent serum titers of VCA–IgG.

Authors:  Bora Dogan; Seyyal Rota; Levent Gurbuzler; Gulendam Bozdayi; Mustafa Nuri Ceyhan; Erdogan Inal
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-01       Impact factor: 2.503

6.  Seroprevalence of cytomegalovirus, Epstein Barr virus and varicella zoster virus among pregnant women in Bradford: a cohort study.

Authors:  Lucy Pembrey; Pauline Raynor; Paul Griffiths; Shelley Chaytor; John Wright; Andrew J Hall
Journal:  PLoS One       Date:  2013-11-27       Impact factor: 3.240

7.  Evolution of EBV seroprevalence and primary infection age in a French hospital and a city laboratory network, 2000-2016.

Authors:  Grégoire Fourcade; Raphaele Germi; Fabrice Guerber; Julien Lupo; Monique Baccard; Arnaud Seigneurin; Touyana Semenova; Patrice Morand; Olivier Epaulard
Journal:  PLoS One       Date:  2017-04-17       Impact factor: 3.240

8.  Cytomegalovirus, Epstein-Barr virus and varicella zoster virus infection in the first two years of life: a cohort study in Bradford, UK.

Authors:  Lucy Pembrey; Dagmar Waiblinger; Paul Griffiths; Mauli Patel; Rafaq Azad; John Wright
Journal:  BMC Infect Dis       Date:  2017-03-21       Impact factor: 3.090

9.  Seroprevalence of Epstein-Barr virus infection in U.S. children ages 6-19, 2003-2010.

Authors:  Jennifer Beam Dowd; Tia Palermo; Jennifer Brite; Thomas W McDade; Allison Aiello
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

10.  Epstein-Barr virus (EBV) infection in Chinese children: a retrospective study of age-specific prevalence.

Authors:  Geng Xiong; Bo Zhang; Mu-yun Huang; Hufeng Zhou; Li-zhen Chen; Qi-sheng Feng; Xi Luo; Hui-jia Lin; Yi-xin Zeng
Journal:  PLoS One       Date:  2014-06-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.